From: Combined anti-C1-INH and radiotherapy against glioblastoma
Treatment (number of animals per group) | Survival (median days ± SD) |
---|---|
Controls (n = 5) | 49 ± 7 |
PBS intratumorally (n = 6) | 49 ± 8 |
Anti-C1-INH intratumorally (n = 6) | 53 ± 7 |
RT 8 Gy × 2 (n = 6) | 74 ± 19 |
RT 8 G × 2 + anti-C1-INH intratumorally (n = 5) | 100 ± 17 |